Abstract
Nocturnal pruritus is a significant problem for patients with inflammatory skin diseases and many systemic diseases. The oral therapies currently available have a limited effect. We present an open, uncontrolled pilot study of 3 patients with inflammatory skin diseases and severe nocturnal pruritus who underwent treatment with mirtazapine (Remeron), a noradrenergic and specific serotonergic antidepressant. Mirtazapine is a safe medication without serious side effects and may be an effective alternative for the treatment of nocturnal pruritus.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 889-891 |
| Number of pages | 3 |
| Journal | Journal of the American Academy of Dermatology |
| Volume | 50 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jan 1 2004 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Dermatology
Cite this
Mirtazapine for reducing nocturnal itch in patients with chronic pruritus : A pilot study. / Hundley, Jennifer L.; Yosipovitch, Gil.
In: Journal of the American Academy of Dermatology, Vol. 50, No. 6, 01.01.2004, p. 889-891.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Mirtazapine for reducing nocturnal itch in patients with chronic pruritus
T2 - A pilot study
AU - Hundley, Jennifer L.
AU - Yosipovitch, Gil
PY - 2004/1/1
Y1 - 2004/1/1
N2 - Nocturnal pruritus is a significant problem for patients with inflammatory skin diseases and many systemic diseases. The oral therapies currently available have a limited effect. We present an open, uncontrolled pilot study of 3 patients with inflammatory skin diseases and severe nocturnal pruritus who underwent treatment with mirtazapine (Remeron), a noradrenergic and specific serotonergic antidepressant. Mirtazapine is a safe medication without serious side effects and may be an effective alternative for the treatment of nocturnal pruritus.
AB - Nocturnal pruritus is a significant problem for patients with inflammatory skin diseases and many systemic diseases. The oral therapies currently available have a limited effect. We present an open, uncontrolled pilot study of 3 patients with inflammatory skin diseases and severe nocturnal pruritus who underwent treatment with mirtazapine (Remeron), a noradrenergic and specific serotonergic antidepressant. Mirtazapine is a safe medication without serious side effects and may be an effective alternative for the treatment of nocturnal pruritus.
UR - http://www.scopus.com/inward/record.url?scp=2542418205&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2542418205&partnerID=8YFLogxK
U2 - 10.1016/j.jaad.2004.01.045
DO - 10.1016/j.jaad.2004.01.045
M3 - Article
C2 - 15153889
AN - SCOPUS:2542418205
VL - 50
SP - 889
EP - 891
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
SN - 0190-9622
IS - 6
ER -